Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Profound Medical Corp
PROF
Primary Symbol:
T.PRN
Healthcare
Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure...
, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:PRN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
(3216)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Nov 04, 2021 4:14pm
Conference Call Details
Profound Medical is pleased to invite all interested parties to participate in a conference call today, November 4, 2021, at 4:30 pm ET during which time the results will be discussed.
...more
(3216)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Nov 04, 2021 4:13pm
Third Quarter 2021 Financial Results
TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 04, 2021 1:43pm
RE:Q3 2021 Financial Results Nov 4 - Conference call to follow
It is interesting that the tulsa procedures list of USA sites hasn't changed over the past 3-4 months. Even though Arun touted hospital agreements in hand. I'm not doubting that he has
...more
(4)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Post by
HomerAndCompany
on Nov 03, 2021 11:30am
Q3 2021 Financial Results Nov 4 - Conference call to follow
Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Third Quarter 2021 Results Conference Call Details
...more
(27)
•••
BuenaSuertaAtod
X
View Profile
View Bullboard History
Post by
BuenaSuertaAtod
on Nov 02, 2021 8:49am
News: PRN to Participate in November Virtual Investor Conf
Profound Medical to Participate in November Virtual Investor Conferences 01 Nov 2021 16:30 ET GlobeNewswire Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Oct 26, 2021 9:48am
RE:RE:Anyone following the strategy in the background ?
Yes ,,, my notes indicate that RadNet had 353 imaging centers around the USA (not all known as RadNet - kept pre-acquisition names) ... while Akumin had 170 imaging centers in eleven states. Akumin
...more
(4)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Comment by
HomerAndCompany
on Oct 26, 2021 9:08am
RE:Anyone following the strategy in the background ?
Another great post MrMugsy! Profound's strategy of more aggressive expansion of recurring non-capital revenue in the US is bound to benefit from partner Akumin's own aggressive expansion. It
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Oct 25, 2021 10:05am
Anyone following the strategy in the background ?
So Profound has partnered with RadNet and Akumin Inc on the imaging centers side of things. Akumin recently made a blockbuster acquisition (Alliance Healthcare Services). As I understand it
...more
(4)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Post by
HomerAndCompany
on Oct 20, 2021 9:46am
Typo: That should be "Cerulean skies" - deep sky blue
Blue skies Smiling at me Nothing but blue skies Do I see ..... (Once the get the momentum going on TULSA-PRO treatments in the US)
(4)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Post by
HomerAndCompany
on Oct 20, 2021 9:04am
Size of prostate treatment market: Cereulean skies for PRN?
From Q2, 2021 MD&A: "The annual incidence of newly diagnosed cases in 2021 is estimated to reach 248,530 in the United States according to the American Cancer Society and in 2018 there were
...more
(27)
•••
BuenaSuertaAtod
X
View Profile
View Bullboard History
Comment by
BuenaSuertaAtod
on Oct 19, 2021 9:02am
RE:RE:RE:RE:RE:Research Capital: Take a pass on Profound Medical
The June, 2017 article says of the sale of Novadaq (with then CEO Menawat): “The $701 million purchase price is a whopping 95.8 percent premium over Novadaq’s current share price and 8.4 times its
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Oct 17, 2021 2:20pm
RE:RE:RE:RE:Research Capital: Take a pass on Profound Medical
This CEO has sold in the past to Stryker ... seems like a fit for PRN but I'm sure there are others. Open to being acquired? Sure would be - just not sure when the value gets to a
...more
(27)
•••
BuenaSuertaAtod
X
View Profile
View Bullboard History
Comment by
BuenaSuertaAtod
on Oct 17, 2021 11:46am
RE:RE:RE:Research Capital: Take a pass on Profound Medical
MrMugsy, I'm thinking that their plans for 25 installations by 2022 & 7 or 8 additional sites per quarter then (with doubled sales & installation teams) and then up to 10 installations
...more
(4)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Post by
HomerAndCompany
on Oct 14, 2021 2:18pm
Reconciling Research Capital Corp projections with PRN Plans
I've been trying to reconcile the following revenue projections from Andre Uddin of Research Capital with what we know of PRN's plans for TULSA-PRO revenue: These are the revenue projections
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario